OOIR: Observatory of International Research

Papers

(The H4-Index of Osteoporosis International is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Dual-energy x-ray absorptiometry scanner mismatch in follow-up bone mineral density testing	664
Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone	241
RE: “Race/ethnic differences in trabecular bone score in mid-life women: the Study of Women’s Health Across the Nation (SWAN)”	80
Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	79
Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study	72
Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteo	71
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy)	59
One versus 2 years of alendronate following denosumab: the CARD extension	54
Correction to: Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture pat	53
The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions	50
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis	43
The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12–19 years	43
RETRACTED ARTICLE: Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case–control study from India	42
Return on investment of fracture liaison services: a systematic review and analysis	42
Follicle-stimulating hormone is associated with low bone mass in postmenopausal women	40
Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture	36
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk	36
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study	35
The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies	33
The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study	32
Epidemiology of pelvic and acetabular fractures in the USA from 2007 to 2014	32
Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization	32
Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nati	31
Artificial intelligence insights into osteoporosis: comment	31
Association between body mass index, bone bending strength, and BMD in young sedentary women	31

Opportunistic measures of bone mineral density at multiple skeletal sites during whole-body CT in polytrauma patients	30
Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023	29
Bisphosphonate drug holidays in osteoporosis according to fracture risk profile	28
Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study	28